Arch Iran Med. 2018;
21(10): 489.
Abstract View: 2179
PDF Download: 1060
Letter to the Editor
Response to the Letter to the Editor
Ehsan Bahramali
1*, Negar Firouzabadi
21 Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
2 Department of Pharmacology & Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
*Corresponding Author: *Corresponding Author: Ehsan Bahramali, MD; Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran. Email: , Email:
ebahramali@gmail.com
Cite this article as: Bahramali E, Firouzabadi N. Response to the letter to the editor. Arch Iran Med. 2018;21(10):489.
Abstract View: 2180
| years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| 2025 | 26 | 30 | 32 | 40 | 41 | 37 | 40 | 80 | 66 | 73 | 8 | |
| 2024 | 12 | 14 | 22 | 15 | 5 | 15 | 14 | 19 | 22 | 28 | 34 | 49 |
| 2023 | 28 | 22 | 11 | 13 | 15 | 21 | 14 | 17 | 20 | 17 | 30 | 19 |
| 2022 | 20 | 31 | 26 | 15 | 21 | 21 | 21 | 16 | 28 | 26 | 28 | 16 |
| 2021 | 22 | 25 | 16 | 21 | 30 | 28 | 21 | 22 | 30 | 22 | 26 | 25 |
| 2020 | 21 | 19 | 20 | 32 | 36 | 19 | 25 | 24 | 22 | 20 | 21 | 13 |
| 2019 | 37 | 25 | 25 | 25 | 30 | 20 | 27 | 30 | 20 | 20 | 20 | 28 |
| 2018 | | | | | | | | | | | 45 | 50 |
PDF Download: 1060
| years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
| 2025 | 6 | 11 | 11 | 9 | 14 | 17 | 27 | 26 | 13 | 19 | 3 | |
| 2024 | 16 | 17 | 5 | 8 | 9 | 13 | 9 | 8 | 10 | 7 | 5 | 5 |
| 2023 | 5 | 6 | 14 | 8 | 13 | 15 | 12 | 22 | 20 | 15 | 30 | 21 |
| 2022 | 5 | 7 | 4 | 1 | 9 | 4 | 2 | 9 | 1 | 1 | 6 | 3 |
| 2021 | 15 | 7 | 6 | 9 | 7 | 10 | 6 | 14 | 9 | 5 | 10 | 7 |
| 2020 | 13 | 19 | 13 | 26 | 16 | 10 | 10 | 4 | 4 | 9 | 2 | 8 |
| 2019 | 28 | 19 | 20 | 16 | 16 | 14 | 8 | 12 | 5 | 14 | 11 | 20 |
| 2018 | | | | | | | | | | | 95 | 42 |